Occupational Exposure during Pregnancy and Effects on Newborns: A Nested Case-Control Study.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Donzelli, Gabriele
  • Peraita-Costa, Isabel
  • Llopis-Morales, Juan
  • Morales-Suarez-Varela, Maria

Abstract

BACKGROUND: The protection of pregnant workers should be based on evidence regarding the risks to reproductive health from exposure to specific work environments and conditions. The objective of this study was to identify the effects on mothers and newborns resulting from environmental exposure to various occupational risks. METHODS: The study cohort was composed of 399 women admitted to the Obstetrics/Postpartum ward at Hospital La Fe in Valencia, Spain. Face-to-face interviews were conducted to establish associations between workplace exposure during pregnancy and its effects on maternal and newborn health. Sex, anthropometric characteristics, and blood gas analysis in arterial and venous umbilical cord blood at delivery were collected. RESULTS: A total of 138 women were exposed to biological and/or chemical risks, 122 to physical risks, and 139 at no risk of exposure. In the group with chemical and/or biological risks, the frequency of women who resorted to in vitro fertilization to achieve the studied pregnancy is less than half of the group exposed to physical risks, with statistically significant differences (p = 0.047). The mean values for the arterial analysis in both exposure groups were within average values, with similar pH values between them, but the mean values of PCO2 and PO2 were lower in the group of neonates of mothers exposed to physical risks, with a significant difference for arterial PO2 (p = 0.027). CONCLUSION: Our analysis contributes evidence for planning and prioritizing preventive actions to protect women's reproductive health. The results suggest the continuation of a future project that would consider more factors and potentially increase the sample size.

Datos de la publicación

ISSN/ISSNe:
0024-3019, 2075-1729

LIFE-BASEL  Multidisciplinary Digital Publishing Institute (MDPI)

Tipo:
Article
Páginas:
-
Factor de Impacto:
0,588 SCImago
Cuartil:
Q2 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Keywords

  • women's occupational exposures; chemical risks; biological risks; physical risks; reproductive health

Proyectos asociados

PAPEL DEL FACTOR DE CRECIMIENTO PLACENTARIO EN EL MANEJO DE LA PREECLAMPSIA NO SEVERA: ESTUDIO ALEATORIZADO

Investigador Principal: ALFREDO JOSÉ PERALES MARÍN

PI15/01935 . INSTITUTO DE SALUD CARLOS III . 2016

ESTUDIO DE FASE IIB/IIIA, MULTICÉNTRICO, ALEATORIZADO, DE GRUPOS PARALELOS, CON ENMASCARAMIENTO DOBLE Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE AMAG-423, UN FRAGMENTO AB DE ANTICUERPOS ANTIDIGOXINA, EN PACIENTES EMBARAZADAS CON PREECLAMPSIA GRAVE.

Investigador Principal: ALFREDO JOSÉ PERALES MARÍN

AMAG-423-201 . 2019

ENSAYO MULTICÉNTRICO, ABIERTO, ALEATORIZADO, DE DOSIS ÚNICA, CONTROLADO, DE XOMA 213 ADMINISTRADO POR VÍA INTRAVENOSA A MUJERES DESPUÉS DEL PARTO PARA LA SUPRESIÓN DE LA LACTANCIA.

Investigador Principal: ALFREDO JOSÉ PERALES MARÍN

X213220

Estudio clínico prospectivo para la realización de un cribado molecular para la detección precoz de preeclampsia en el primer trimestre de embarazo.

Investigador Principal: ALFREDO JOSÉ PERALES MARÍN

IGX1-PRE-CS-20-11 . 2022

Prevención de la obesidad de por vida mediante la identificación temprana de factores de riesgo, pronóstico e intervención.

Investigador Principal: ISAURO ROGELIO MONFORT ORTIZ

FCS-OBE-CS-22-3 . 2023

Estudio clínico para entender la contribución materna en el origen y causas de la preeclampsia mediante secuenciación a nivel de célula única.

Investigador Principal: ISAURO ROGELIO MONFORT ORTIZ

FCS-EMB-TG-23-02 . 2023

Estudio molecular de la interfase materna-fetal de forma prospectiva a la aparición de preeclampsia mediante tecnología de célula única.

Investigador Principal: BEATRIZ MARCOS PUIG

FCS-IMF-TG-23-03 . 2023

Cita

Compartir